Paradice Investment Management LLC increased its position in Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 2.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,293,198 shares of the company's stock after buying an additional 30,949 shares during the period. Avanos Medical comprises 4.1% of Paradice Investment Management LLC's portfolio, making the stock its 14th largest holding. Paradice Investment Management LLC owned approximately 2.81% of Avanos Medical worth $20,588,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also modified their holdings of the company. Quarry LP purchased a new position in shares of Avanos Medical during the third quarter valued at approximately $42,000. KBC Group NV lifted its stake in shares of Avanos Medical by 63.0% during the third quarter. KBC Group NV now owns 2,833 shares of the company's stock valued at $68,000 after buying an additional 1,095 shares during the period. Intech Investment Management LLC purchased a new position in shares of Avanos Medical during the third quarter valued at approximately $207,000. Atom Investors LP purchased a new position in shares of Avanos Medical during the third quarter valued at approximately $210,000. Finally, EP Wealth Advisors LLC purchased a new position in shares of Avanos Medical during the third quarter valued at approximately $212,000. Hedge funds and other institutional investors own 95.17% of the company's stock.
Avanos Medical Trading Up 0.0 %
Shares of AVNS traded up $0.01 on Friday, hitting $15.49. 350,491 shares of the stock traded hands, compared to its average volume of 545,288. The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12. The firm has a market capitalization of $711.78 million, a P/E ratio of 45.55 and a beta of 0.98. Avanos Medical, Inc. has a 1 year low of $14.98 and a 1 year high of $25.36. The stock's 50 day moving average is $16.22 and its two-hundred day moving average is $19.87.
Analyst Upgrades and Downgrades
Separately, StockNews.com downgraded shares of Avanos Medical from a "strong-buy" rating to a "buy" rating in a research note on Sunday, November 3rd.
Check Out Our Latest Report on AVNS
Avanos Medical Profile
(
Free Report)
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
See Also
Before you consider Avanos Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avanos Medical wasn't on the list.
While Avanos Medical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
